This is a good question. It also highlights the danger of a lay-interpretation of these results.
It is certainly already known that exposure to one viral strain can weaken response to others. But this fact has to be taken as part of a body of knowledge on how these effects balance each other to come to any kind of cost-benefit conclusions.